Dermatomyosites à anticorps anti-MDA5 : atteinte pulmonaire sévère précoce mais aussi tardive

La Revue de Médecine Interne - Tập 39 - Trang A122 - 2018
A. Bichon1, T. Escoda1, F. Mariette1, J. Seguier1, N. Ené1, L. Swiader1, M. Ebbo1, N. Schleinitz1, J. Harlé1, J. Durand1
1Médecine interne, AP–HM, Marseille 05, Provence-Alpes-Côte d’Azur, France

Tài liệu tham khảo

Ikeda, 2015, Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody : to lump or split?, BMC Pulmonary Med, 15, 159, 10.1186/s12890-015-0154-4 Endo, 2018, Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: a case report. NA., ed, Medicine, 97, e11024, 10.1097/MD.0000000000011024 Labrador-Horrillo, 2014, Anti-MDA5 Antibodies in a large Mediterranean population of adults with dermatomyositis, J Immunol Res, 2014, 290797, 10.1155/2014/290797